|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
NZ579372A
(en)
*
|
2007-03-07 |
2012-02-24 |
Janssen Pharmaceutica Nv |
Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
|
|
ATE516272T1
(de)
|
2007-09-14 |
2011-07-15 |
Ortho Mcneil Janssen Pharm |
1,3-disubstituierte 4-(aryl-x-phenyl)-1h-pyridin- 2-one
|
|
WO2009033703A1
(en)
|
2007-09-14 |
2009-03-19 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
|
|
RS51660B
(sr)
|
2007-09-14 |
2011-10-31 |
Ortho-Mcneil-Janssen Pharmaceuticals Inc. |
1`,3`-disupstituisani-4-fenil-3,4,5,6-tetrahidro-2h, 1`h-[1,4`] bipiridinil-2`-oni
|
|
EP2220083B1
(en)
|
2007-11-14 |
2017-07-19 |
Janssen Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
WO2009105621A1
(en)
*
|
2008-02-22 |
2009-08-27 |
The Ohio State University Research Foundation |
Androgen receptot-ablative agents
|
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
|
AU2009304293B2
(en)
|
2008-10-16 |
2012-04-26 |
Addex Pharma S.A. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
|
JP5690277B2
(ja)
|
2008-11-28 |
2015-03-25 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
US8937060B2
(en)
|
2009-05-12 |
2015-01-20 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
|
|
KR20120035158A
(ko)
|
2009-05-12 |
2012-04-13 |
얀센 파마슈티칼즈, 인코포레이티드 |
1,２,４?트리아졸로［４,３?ａ］피리딘 유도체 및 ｍＧｌｕＲ２ 수용체의 양성 알로스테릭 조절자로서의 그의 용도
|
|
JP2011057644A
(ja)
*
|
2009-09-14 |
2011-03-24 |
Sumitomo Chemical Co Ltd |
３型１７β−ヒドロキシステロイドデヒドロゲナーゼを阻害するための化合物の使用およびそのための医薬組成物
|
|
JP2011057643A
(ja)
*
|
2009-09-14 |
2011-03-24 |
Sumitomo Chemical Co Ltd |
３型１７β−ヒドロキシステロイドデヒドロゲナーゼを阻害するための化合物の使用およびそのための医薬組成物
|
|
TW201144303A
(en)
|
2010-02-17 |
2011-12-16 |
Janssen Pharmaceutica Nv |
Aminothiazolones as estrogen related receptor-α modulators
|
|
CA2814996C
(en)
|
2010-11-08 |
2019-10-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
CN103298809B
(zh)
|
2010-11-08 |
2016-08-31 |
杨森制药公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
EP2643320B1
(en)
|
2010-11-08 |
2015-03-04 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
WO2012153775A1
(ja)
*
|
2011-05-10 |
2012-11-15 |
国立大学法人神戸大学 |
Ras機能阻害作用を有するチオキソチアゾリジン誘導体
|
|
WO2013018929A1
(en)
|
2011-08-04 |
2013-02-07 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing heterocyclic compound
|
|
CN102949364A
(zh)
*
|
2011-08-30 |
2013-03-06 |
天津药物研究院 |
一种含有效成分盐酸维拉佐酮的缓释片
|
|
JP5865995B2
(ja)
|
2012-03-26 |
2016-02-17 |
日本ケミファ株式会社 |
骨・軟部に発生する巨細胞性腫瘍または軟骨肉腫の予防または治療剤
|
|
EP2909333A1
(en)
*
|
2012-10-17 |
2015-08-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for predicting and treating bone metastases in prostate cancer patients
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
KR20160055932A
(ko)
|
2013-09-25 |
2016-05-18 |
닛뽕 케미파 가부시키가이샤 |
골·연부에 발생하는 거세포성 종양, 연골육종 또는 골육종의 예방, 치료 또는 전이 예방을 위한 약제, 동맥색전술용 국소 주입제 및 인공골
|
|
HRP20191646T1
(hr)
|
2014-01-21 |
2019-12-13 |
Janssen Pharmaceutica Nv |
Kombinacije koje sadržavaju pozitivne alosteričke modulatore ili ortosteričke agoniste metabotropnog glutamatergičnog receptora podtip 2 i njihova uporaba
|
|
CN109999033B
(zh)
|
2014-01-21 |
2022-12-23 |
詹森药业有限公司 |
包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
US10071164B2
(en)
|
2014-08-11 |
2018-09-11 |
Yale University |
Estrogen-related receptor alpha based protac compounds and associated methods of use
|
|
KR20180097530A
(ko)
|
2015-11-02 |
2018-08-31 |
예일 유니버시티 |
단백질분해 표적화 키메라 화합물(Proteolysis Targeting Chimera compound) 및 그의 제조 및 사용 방법
|
|
EP3840749B1
(en)
*
|
2018-08-22 |
2023-08-09 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Compounds for treating cardiac valve disease
|
|
EP3870292A4
(en)
|
2018-10-26 |
2022-11-09 |
The Research Foundation for The State University of New York |
COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
|
|
CN112538038B
(zh)
*
|
2019-09-20 |
2022-05-20 |
暨南大学 |
2-吲哚酮类ERRα反向激动剂及其药物组合物和应用
|